Mylan Secures Summary Judgment In EpiPen Misrepresentation Suit
NEW YORK — A federal judge in New York ruled that lead plaintiffs in a securities class action lawsuit against drugmaker Mylan N.V. and certain of its current and former executive...To view the full article, register now.
Already a subscriber? Click here to view full article